{
    "organizations": [],
    "uuid": "3d32950a055a979c59231e51042af0d399772b0e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-egypts-minapharm-pharmaceuticals-f/brief-egypts-minapharm-pharmaceuticals-fy-standalone-profit-rises-idUSFWN1RB048",
    "ord_in_thread": 0,
    "title": "Egypt's Minapharm Pharmaceuticals FY Standalone Profit Rises",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - MINAPHARM PHARMACEUTICALS SAE :\n* FY STANDALONE NET PROFIT EGP 61.9 ‍​MILLION VERSUS EGP 40.5 ‍​MILLION YEAR AGO\n* FY STANDALONE NET SALES EGP 1.24 BILLION VERSUS EGP 905.3 MILLION YEAR AGO Source:( bit.ly/2IbaIhC ) Further company coverage:\n ",
    "published": "2018-03-29T15:46:00.000+03:00",
    "crawled": "2018-03-30T13:01:22.070+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "minapharm",
        "pharmaceutical",
        "sae",
        "fy",
        "standalone",
        "net",
        "profit",
        "egp",
        "versus",
        "egp",
        "year",
        "ago",
        "fy",
        "standalone",
        "net",
        "sale",
        "egp",
        "billion",
        "versus",
        "egp",
        "million",
        "year",
        "ago",
        "source",
        "company",
        "coverage"
    ]
}